Table 2.
Small molecules able to inhibit autophagic activity
Agents
|
Mechanism of action
|
3-Methyladenine (3-MA) | Inhibitor of class III PI3K |
LY294002 | PI3K inhibitor |
Wortmannin | PI3K inhibitor |
SB202190 | Cross-inhibition of the PI3K/mTOR and MAPKs pathway |
MHY1485 | Activator of mTOR |
Azithromycin | Inhibitor of v-ATPase, inhibition of lysosomal acidification |
Bafilomycin A1 | Inhibitor of v-ATPase, inhibition of lysosomal acidification |
Concanamycin A | Inhibitor of v-ATPase, inhibition of lysosomal acidification |
Chloroquine (CQ) | Autophagosome-lysosome fusion |
Hydroxy-chloroquine (HCQ) | Autophagosome-lysosome fusion |
Clomipramine | Alter acidification of lysosomes |
Verteporfin | Alter acidification of lysosomes |
Paclitaxel | Microtubule stabilizer- inhibit phosphorylation of VPS34 at T159 |
Spain-1 | Inhibits the activity of ubiquitin-specific peptidases, USP10 and USP13 |
Monensin | Inhibit autophagosome-lysosome fusion |
PI3K: Phosphatidylinositol 3-kinases; mTORC1: Mammalian target of rapamycin complex 1; AMPK: 5’ AMP-activated protein kinase;VPS: Vacuolar protein sorting; ATG: Autophagy-related proteins; USP: Ubiquitin-specific protease.